Episode Summary
Executive Summary: In this Thanksgiving episode of the All-In podcast, the hosts celebrate David Friedberg's second company, MetroMile, going public via a SPAC, with Chamath Palihapitiya joining as a PIPE investor. They discuss the transformative potential of usage-based auto insurance, the success of Operation Warp Speed in developing COVID-19 vaccines, the promise of mRNA technology, and the need for regulatory reform to enable challenge trials and permissionless innovation. The conversation also touches on SEC deregulation, the importance of allowing individuals to assume risk, and the potential for a new regulatory framework that empowers entrepreneurs and individuals.
Main Topics: MetroMile SPAC and Usage-Based Insurance (Priority: 5/5): David Friedberg announces MetroMile going public via a SPAC, with Chamath as a PIPE investor. The company offers pay-per-mile auto insurance, using telematics to track mileage and driving behavior, saving average customers 47% compared to traditional insurers. The model is positioned as fairer and more dynamic, especially with the rise of autonomous vehicles. COVID-19 Vaccine Development and Operation Warp Speed (Priority: 5/5): The hosts analyze the rapid development of mRNA vaccines by Pfizer and Moderna, crediting Operation Warp Speed for parallelizing production and cutting red tape. They discuss the timeline for herd immunity (by May 2021) and the potential for mRNA technology to revolutionize future vaccine development. Challenge Trials and Regulatory Reform (Priority: 4/5): The group debates the ethics and necessity of human challenge trials for vaccines, contrasting them with other risky activities like smoking or gambling. They argue that regulatory capture and outdated laws slow innovation, and advocate for permissionless innovation and individual risk assumption. SEC Deregulation and Access to Investment (Priority: 3/5): Jason Calacanis highlights recent SEC changes allowing gig workers to receive stock compensation and expanding accredited investor definitions. The hosts see this as a positive step toward democratizing wealth creation and reducing the 'nanny state' in investing. Regulatory Capture and the Need for a New Deal (Priority: 4/5): Chamath calls for a wholesale rewrite of regulatory infrastructure to account for technology, criticizing how lobbyists and entrenched interests stifle innovation. The group discusses the challenge of representing future entrepreneurs in Washington.
Key Arguments: Usage-based insurance (pay-per-mile) is fairer and more dynamic than traditional models, with 70% of price variance driven by miles driven, not behavior. Operation Warp Speed succeeded by parallelizing production and avoiding political interference, though the Trump administration's credibility issues prevented political benefit. mRNA technology enables rapid vaccine development; future pandemics could see vaccines produced in days, but human trials remain the bottleneck. Challenge trials should be allowed for willing, informed participants, as they accelerate vaccine development and are no riskier than other permitted activities. Regulatory capture in pharmaceuticals and other industries slows innovation; a new regulatory framework is needed to empower entrepreneurs and individuals. SEC deregulation under Jay Clayton has expanded investment access, helping middle Americans build wealth in a low-interest-rate environment.
Data Points: Average savings for MetroMile customers: 47% - Compared to traditional insurers like Geico or Progressive. Price variance from miles driven: 70% - Only 30% is from driving behavior. U.S. population infected by COVID-19 as of June 30: 10% - Based on dialysis patient antibody study. Estimated current U.S. infection rate: 30% - Extrapolated from June data and subsequent cases. Vaccine efficacy: 90-95% - For Pfizer and Moderna vaccines. Projected herd immunity timeline: May 2021 - Fauci's estimate for 70% immunization. Doses available in December/January/February: 40-60 million - From Pfizer and Moderna in the U.S.
Pivotal Quotes: "Buffett had Geico. I picked Metro Mile." — Chamath Palihapitiya: Tweeting about MetroMile's SPAC, comparing it to Warren Buffett's investment in Geico. "The reason why innovation has happened so fast on the internet is because of one word: permissionless." — David Sacks: Arguing that permissionless innovation is key to progress, contrasting with heavily regulated industries. "It does not make sense in the United States of America... that you can buy alcohol and drink yourself into the ground... but you can't participate in a thoughtful trial backed by scientific research." — Chamath Palihapitiya: Criticizing the inconsistency in allowing risky personal behaviors while banning challenge trials.
Implications: The podcast suggests a future where insurance is dynamically priced, vaccines are rapidly developed via mRNA, and regulatory reforms empower individuals and entrepreneurs. This could lead to faster innovation, greater wealth access, and a more resilient society, but requires overcoming entrenched interests and updating outdated laws.
About This Week in Startups
Jason Calacanis covers startups, tech, markets, media, and all the hottest topics in business and technology. He also interviews the world’s greatest founders, operators, investors, and innovators.